The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug ...

This Philly-based company is using AI to predict which medical research can lead to profitable drugs and therapies Clarivate ...

Eli Lilly has proposed investing $5.9 billion to build a pharmaceutical facility in Houston's Generation Park.

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...

The biopharma company said it filled the newly created role of chief operating officer to lead its commercial strategy, ...

The clinical-stage biotech company is based in Sacramento, and is putting its drug candidate through medical trials.

Samsung Biologics Co. said it plans to carve its business into a contract drug manufacturer and a holding firm which will ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...

President Donald Trump signed an executive order on Monday aimed at lowering prescription drug prices in the U.S. Here's what ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

The Department of Health and Human Services today announced it has identified specific pricing targets for pharmaceutical ...